<DOC>
	<DOC>NCT00535756</DOC>
	<brief_summary>This study will provide efficacy data for Creon 25000 MMS in PS patients as well as long-term safety data. During the long-term treatment with Creon 25000 nutritional parameters will be assessed and correlated with CFA</brief_summary>
	<brief_title>Creon After Pancreatic Surgery</brief_title>
	<detailed_description />
	<mesh_term>Exocrine Pancreatic Insufficiency</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Inclusion Criteria Pancreatic exocrine insufficiency has to be proven (in medical history) by the following criteria: Direct or indirect pancreatic function test (except stool fat excretion) and Steatorrhoea: stool fat &gt; 15 g/day (using van de Kamer method) Proven chronic pancreatitis Females of childbearing potential must agree to continue using a medically acceptable method of birth control Exclusion Criteria Subjects in an unstable situation (catabolic) after pancreatic surgery Ileus or acute abdomen Current excessive intake of alcohol or drug abuse Hypersensitivity vs porcine proteins / pancreatin Subjects taking digestive enzyme preparations have to stop them before start of the runin period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Pancreatic Exocrine Insufficiency After Pancreatic Surgery</keyword>
</DOC>